Viral hepatitis is a global epidemic, causing 1.34 million deaths per year. The World Health Organization (WHO) officially endorses World Hepatitis Day (WHD) which takes place on 28th July every year.
Synergy Pharmaceuticals Inc. announced that the FDA has approved Trulance (plecanatide) 3 mg tablet for the once-daily treatment of irritable...
Sage Therapeutics reported topline results from the pivotal Phase III MOUNTAIN Study evaluating the effect of SAGE 217 (zuranolone) on...
Background: Eculizumab is approved for atypical hemolytic uremic syndrome (aHUS). Guidelines discuss the importance of prompt treatment.
This guideline aims to summarise the current literature guiding the use of red cell transfusion in critically ill patients and provides recommendations to support clinicians in their day-to-day practice.
Objective: To determine whether tocilizumab (TCZ) improves outcomes of patients hospitalized with moderate-to-severe COVID-19 pneumonia.
Eli Lilly and Company and Incyte announced results from an additional cohort of 101 adult patients from the COV-BARRIER trial.
Mixed results from HEALOS Phase III trial of AM 111 to treat profound sudden deafness
World Head and Neck Cancer day 27th July 2024
Kala Pharmaceuticals, Inc.announced topline results from Phase III clinical trials (STRIDE - Short Term Relief In Dry Eye).